Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.205 USD -5.86% Market Closed
Market Cap: 221.8m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Relative Value

The Relative Value of one NKTR stock under the Base Case scenario is 0.692 USD. Compared to the current market price of 1.205 USD, Nektar Therapeutics is Overvalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NKTR Relative Value
Base Case
0.692 USD
Overvaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
39
Median 3Y
2.7
Median 5Y
7.8
Industry
2.6
Forward
2.6
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.7
Industry
23
Forward
-1.4
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.8
Industry
17.8
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.8
Industry
25.4
vs History
15
vs Industry
38
Median 3Y
1.5
Median 5Y
2.4
Industry
2.2
vs History
vs Industry
91
Median 3Y
-0.4
Median 5Y
1.8
Industry
2.8
Forward
-0.6
vs History
vs Industry
87
Median 3Y
-0.7
Median 5Y
2.3
Industry
5.4
vs History
33
vs Industry
53
Median 3Y
0.3
Median 5Y
-0.6
Industry
13.7
Forward
0.3
vs History
33
vs Industry
49
Median 3Y
0.3
Median 5Y
-0.5
Industry
17.2
Forward
0.3
vs History
33
vs Industry
54
Median 3Y
0.2
Median 5Y
-0.4
Industry
16.5
vs History
33
vs Industry
40
Median 3Y
0.2
Median 5Y
-0.4
Industry
19.3
vs History
vs Industry
84
Median 3Y
-0.5
Median 5Y
0.7
Industry
2

Multiples Across Competitors

NKTR Competitors Multiples
Nektar Therapeutics Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Nektar Therapeutics
NASDAQ:NKTR
221.8m USD 2.4 -1.3 0.4 0.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Nektar Therapeutics
NASDAQ:NKTR
Average P/E: 33.3
Negative Multiple: -1.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top